PharmaShots

FEBRUARY 17, 2023

Iveric Bio Reports the US FDA Acceptance of NDA and Granted Priority Review of Avacincaptad Pegol for Geographic Atrophy Date: Feb 17, 2023 | Tags: Iveric Bio, Avacincaptad Pegol, Geographic Atrophy, Regulatory, US, FDA, NDA, Priority Review ALX Oncology Reports the First Patient Dosing of Evorpacept in the P-I Study (ASPEN-07) for the Treatment of (..)

FDA 40

FDA Vaccines 40

European Pharmaceutical Review

JUNE 8, 2023

Inefficient and costly downstream processing strategies are, according to some authors, the main driver of manufacturing /production costs for emerging bioproducts, the paper noted. Methods of the microbial biosurfactant study The first stage of the downstream method combined TAG selective removal from glycolipids.

66

66

Pharmaceutical Technology

JULY 14, 2022

The commercial investment required to research and develop an innovative drug, prove its safety and efficacy, and bring it to market is staggering. Go-to-market strategies. Each country in Europe carries unique complexities, which makes it difficult for companies to deploy turnkey commercial strategies on a pan-European level.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Hospitals 59

Viseven

JUNE 23, 2022

The most successful of them create strategies to foresee the challenges of tomorrow. Modular content approach with omnichannel strategies: why they fit each other. Let’s figure out how exactly this approach influences the commercial part of digital marketing. Why is it great for commercial purposes?

Communication 52

Communication 52

The Checkup by Singlecare

AUGUST 31, 2023

Fortunately, a few savings strategies can help reduce the cost of Mounjaro. Compounded drugs do not have the same FDA regulations and oversight as commercially available products. With a monthly price tag of $1,580, Mounjaro is no exception. Mounjaro can only be purchased at a premium price.

Insurance 98

Insurance Compounding Insurance Coverage Labelling 98

pharmaphorum

DECEMBER 23, 2022

price tag of $475,000 when it was first launched in 2017 – and it becomes apparent that these may not be desirable treatment options for every patient and in every setting. Add to this the considerable cost of these medications – the first approved CAR-T, Novartis’ Kymriah (tisagenlecleucel), had a U.S.

Immunization 52

Immunization Hospitals Vaccines 52

PharmaShots

MARCH 9, 2023

Designation: Chief Commercial Officer (CCO) and President Award & Nominations: She has her mention in Fortune’s “Top 50 Most Powerful Women” in 2020, 2021, and 2022 ranking 16th, 11th, and 13th respectively. She is an expert in trial design, strategy, and data analysis. LinkedIn Total experience: 26 yrs.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40